{
  "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37",
  "docSlug": "b2317289d3b06d938a683c10bc0d40e0",
  "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides",
  "authorId": "organicell-regenerative-medicine",
  "authorName": "Organicell Regenerative Medicine",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 17,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "context",
  "function": "establish_context",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/6",
  "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37",
  "deckJsonHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37.json",
  "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.11,
        "x": 0.85,
        "y": 0.04
      },
      "kind": "image",
      "text": "Organicell",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b7667153-4f66-4025-b57c-f0d17d4f56f2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "image",
      "text": "Mayo Clinic, Zofin, Proxima, FactorX, PPX, Xotin, Hydrafacial, Apex, Goldfaden MD",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34fd5a2c-599d-4770-aaf1-89a7acb83c3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.22,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "list",
      "text": "FDA-Approved Clinical Trials: Covid Long Haulers (Enrolling), COPD (Enrolling), Osteoarthritis (On Pause)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7e717e6f-3a3b-4dd0-b2a7-624171402c38",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.21,
        "x": 0.27,
        "y": 0.65
      },
      "kind": "list",
      "text": "Investigative New Drugs (IND's): Monkey Pox (Drafting), Skin (Scheduled)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aaa56212-513e-432a-a15e-9e39f9dbab3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.8,
        "x": 0.04,
        "y": 0.14
      },
      "kind": "paragraph",
      "text": "Organicell Regenerative Medicine, Inc. (OCEL) is comprised of two arms: Clinical Research and Commercial. Organicell is focused on the characterization and utility of extracellular vesicles (also known as Exosomes.)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37ecc658-7843-4708-9fd2-b7e0f2118194",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.43,
        "x": 0.05,
        "y": 0.34
      },
      "kind": "paragraph",
      "text": "Clinical Research: Organicell is actively studying the efficacy and safety of our flagship product Zofin through FDA-approved Phase I / II Clinical Trials for Long COVID, COPD, and Osteoarthritis.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "edf25982-b4da-44e0-b816-08eecde84e5d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.43,
        "x": 0.52,
        "y": 0.34
      },
      "kind": "paragraph",
      "text": "Commercial: To supplement operational expenses during clinical trials, we monetize our lab resources and technology through the sale of extracellular vesicle products.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8ace5db-7a7e-46e7-b55c-085287203051",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.35,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Understanding Organicell",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d902627-b9d9-47f9-81d1-3d2cbcaecba4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}